Nick Guldemond

Nick Guldemond

Professor Healthcare & Public Health, Leiden University Medical Center, Netherlands

Nick has a background in Electric Engineering, Medicine and Life Sciences. During his study he was an assistant at dept. Anatomy & Embryology at the Fac. Medicine, Leiden University. In 1993 he applied as a assistant on a project regarding self management of osteoarthritis at TNO. In 1995 he graduated ‘Magna Cum Laude’ on the screening of cognitive function in children after traumatic brain injury supervised by Dr. Van Cranenburgh (Institute of applied neurosciences) He continued his study at Free University Amsterdam Fac. Medicine with a curriculum oriented on neurosciences. In 1997 he was appointed as researcher at Free University for the project ‘The QoL and neuropsychologic status of patients with glioma’ he was assigned to dept Epidemiology at NL Cancer Institute supervised by Prof. Aaronson. In 1999 he started as a PhD student at dept of Orthopaedic Surgery (University Maastricht), which resulted in a thesis on diabetic foot complications. He was CEO & founder of the Medical Field Lab ie health innovation, for which he obtained prestigious research grants.He worked on innovation and medical curriculum development for different universities. Dr. Guldemond senior researcher at Leiden University and Prof. Integrated Care & Technology at I.M. Sechenov First Moscow State Medical University. He is policy advisor for the Health Ministry and consultant for various organisations: WHO, EU Programmes EIT KIC Health, KIC Digital, AAL, IMI and H2020. He is active numerous eHealth programmes: China, UK, Russian Federation, Italy, Norway, Poland, Germany, Belgium, Brazil, Iran, Finland, Romania and US. Often in collaboration with industry Pharma (Roche, Genzyme, J&J, Grunenthal), Medtech (Philips, MEDTRONIC, COCIR), Health IT (Microsoft, Ascom, Ortec, Vodafone) and finance (Rabobank, Natwest, RBS). He was architect of the national eHealth and Big Data strategy. He is coordinator of EU EIP on Healthy and Active Ageing and member of the ISO Strategic Advisory Group on Ageing Societies.